EGFR and non-small cell lung carcinoma: Leptomeningeal carcinomatosis (LMC) remains a devastating complication of epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer despite the availability of central nervous system (CNS)-active EGFR tyrosine kinase inhibitors (TKIs).